RECURRENT GLIOMA
Clinical trials for RECURRENT GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test living drug against deadly brain tumors
Disease control Recruiting nowThis is a first-in-human study testing a new cell therapy called CARv3-TEAM-E for glioblastoma, an aggressive brain cancer. Researchers will collect a patient's own immune cells, genetically modify them to target cancer, and reinfuse them to see if they can safely fight the tumor…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE1 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Targeted pill tested to control recurrent brain tumors
Disease control Recruiting nowThis study is testing whether a pill called erdafitinib can help control a specific type of recurrent brain tumor (glioma) that has a particular genetic change. It is for adults whose tumors have grown back or worsened after initial treatment. The drug aims to block a faulty prot…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New Four-Target cancer antibody enters first human trials
Disease control Recruiting nowThis is an early-stage study to test the safety and initial effects of a new experimental drug called GNC-039 in adults with advanced solid tumors that have returned or spread after standard treatments. The main goals are to find a safe dose and see what side effects occur. Resea…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
App aims to bring brain tumor care home
Disease control Recruiting nowThis study is testing whether a mobile app can help deliver and monitor treatment for adults with glioma brain tumors from home. The goal is to improve access to specialized care for patients who live far from major cancer centers or face other barriers. Participants will use the…
Matched conditions: RECURRENT GLIOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC